Role of ROC1 protein in the control of cyclin D1 protein expression in skin melanomas

Pathology Research and Practice

Volumn 207, Issue 3, 2011, Pages 174-181

  Nai, Gisele ^a   Marques, Mariângela ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

CCND1 gene; Cyclin D1; Melanoma; ROC1 protein; Ubiquitination

Indexed keywords

CYCLIN D1; PROTEIN ROC1; RING FINGER PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MELANOCYTIC NEVUS; MELANOMA; PRIMARY TUMOR; SKIN CANCER; SKIN CARCINOGENESIS; SKIN MELANOMA; TISSUE LEVEL;

EID: 79952390921     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.01.001     Document Type: Article

References (32)

1. Alberts B., Johnson A., Lewis J., et al. Molecular Biology of the Cell 2004, Garland Science Publishing, London.
2. Bastian B.C., Leboit P.E., Hamm H., et al. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res. 1998, 58:2170-2175.
3. Bastian B.C., Olshen A.B., Leboit P.E., Pinkel D. Classifying melanocytic tumors based on DNA copy number. Am. J. Pathol. 2003, 63:1765-1770.
4. Bastian B.C. Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer. Oncogene 2003, 22:3081-3086.
5. Carlson J.A., Ross J.S., Slominski A.J. New techniques in dermatopathology that help to diagnose and prognosticate melanoma. Clin. Dermatol. 2009, 27:75-102.
6. Carrano A.C., Pagano M. Role of the F-box protein Skp2 in adhesion-dependent cell cycle progression. J. Cell Biol. 2001, 153:1381-1390.
7. Chen A., Wu K., Fuchs S.Y., et al. The conserved RING-H2 finger of ROC1 is required for ubiquitin ligation. J. Biol. Chem. 2000, 275:15432-15439.
8. Ciechanover A., Orian A., Schwartz A.L. The ubiquitin-mediated proteolytic pathway: mode of action and clinical implications. J. Cell. Biochem. 2000, 34:40-51.
9. Ciechanover A., Orian A., Schwartz A.L. Ubiquitin-mediated proteolysis: biological regulation via destruction. Bioessays 2000, 22:442-451.
10. Curtin J.A., Fridlyand J., Kageshita T., et al. Distinct sets of genetic alterations in melanoma. N. Engl. J. Med. 2005, 353:2135-2147.
11. Deshaines R.J. SCF and cullin/Ring H2-based ubiquitin ligases. Annu. Rev. Cell Dev. Biol. 1999, 15:435-467.
12. Fukushi M., Imamura T., Chiba T., et al. Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins. Mol. Biol. Cell 2001, 12:1431-1443.
13. Furukawa M., Ohta T., Xiong Y. Activation of UBC5 ubiquitin-conjugating enzyme by the RING finger of ROC1 and assembly of active ubiquitin ligases by all cullins. J. Biol. Chem. 2002, 277:15758-15765.
14. Hershko A., Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 1989, 67:425-427.
15. Kamura T., Browe C.S., Conaway R.C., Conaway J.W. A molecular basis for stabilization of the von Hippel-Lindau (VHL) tumor suppressor protein by components of VHL ubiquitin. J. Biol. Chem. 2002, 277:30388-30393.
16. Kamura T., Koepp D.M., Conrad M.N., et al. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science 1999, 284:657-661.
17. Lebe B., Pabuççuoglu U., Ozer E. The significance of ki-67 proliferative index and cyclin D1 expression of displastic nevi in the biologic spectrum of melanocytic lesions. Appl. Immunohistochem. Mol. Morphol. 2007, 15:160-164.
18. Li W., Sanki A., Karim R.Z., et al. The role of regulatory proteins in pathogenesis of melanoma. Pathology 2006, 38:287-301.
19. Maeda I., Ohta T., Koizumi H., Fukuda M. In vitro ubiquitination of cyclin D1 by ROC1-CUL-1 and ROC1-CUL-3. FEBS Lett. 2001, 494:181-185.
20. Nai G.A., Marques M.E.A. ROC1 protein, cell cycle and cancer. Appl. Cancer Res. 2008, 28:42-47.
21. Ohta T., Michel J.J., Schottelius A.J., Xiong Y. ROC1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity. Mol. Cell 1999, 3:535-541.
22. Périn J.-P., Seddiqi N., Charbonnier F., et al. Genomic organization and expression of the ubiquitin-proteassome complex-associated protein Rbx1/ROC1/Hrt1. Cell. Mol. Biol. 1999, 45:1131-1137.
23. Peters J.M. SCF and APC: the Yin and Yang of cell cycle regulated proteolysis. Curr. Opin. Cell Biol. 1998, 10:759-768.
24. Russell A., Thompson M.A., Hendley J., et al. Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer. Oncogene 1999, 18:1983-1991.
25. Sálvio A.G., Marques M.E.A. Immunohistochemistry for identification of neoplasic cells within brisk infiltrate of thin melanomas. J. Bras. Patol. Med. Lab. 2006, 42:143-148.
26. Sasagawa Y., Urano T., Kohara Y., et al. Caenorhabditis elegans RBX1 is essential for meiosis, mitotic chromosomal condensation and segregation, and cytokinesis. Genes Cells 2003, 8:857-872.
27. Sauter R.E., Yeo U., Von Stemm A., et al. Cyclin D1 is a candidate oncogene in cutaneous melanoma. Cancer Res. 2002, 26:3200-3206.
28. Seol J.H., Feldmen R.M., Zacharie W., et al. Cdc53/cullin and essential Hrt1 RING-H2 subunit of SCF define an ubiquitin ligase module that activates the E2 enzyme Cdc34. Genes Dev. 1999, 13:1614-1626.
29. Stefanaki C., Stefanaki K., Antoniou C., et al. G1 cell cycle regulators in congenital melanocytic nevi. Comparasion with acquired nevi and melanomas. J. Cutan. Pathol. 2008, 10.1111/j.1600-0560.2007.00912.x.
30. Tan P., Fuchs S.Y., Chen A., et al. Recruitment of ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of I kappa B alpha. Mol. Cell 1999, 3:527-533.
31. Yamamura M., Takata M., Miyasaki A., et al. Specific dermoscopy patterns and amplifications of the cyclin D1 gene to define histopathologically unrecognizable early lesions of acral melanoma in situ. Arch. Dermatol. 2005, 141:1413-1418.
32. Yu Z.K., Gervais G.L., Zhang H. Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21 (CIP1/WAF1) and cyclin D proteins. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:11324-11329.